Compare ROST & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROST | ZTS |
|---|---|---|
| Founded | 1982 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.4B | 53.9B |
| IPO Year | N/A | 2013 |
| Metric | ROST | ZTS |
|---|---|---|
| Price | $189.37 | $126.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 11 |
| Target Price | ★ $178.27 | $174.60 |
| AVG Volume (30 Days) | 2.3M | ★ 5.9M |
| Earning Date | 11-20-2025 | 02-12-2026 |
| Dividend Yield | 0.87% | ★ 1.69% |
| EPS Growth | 0.76 | ★ 11.64 |
| EPS | ★ 6.40 | 5.94 |
| Revenue | ★ $22,027,348,000.00 | $9,397,000,000.00 |
| Revenue This Year | $8.47 | $3.04 |
| Revenue Next Year | $5.32 | $4.98 |
| P/E Ratio | $29.20 | ★ $21.17 |
| Revenue Growth | ★ 3.71 | 2.68 |
| 52 Week Low | $122.36 | $115.25 |
| 52 Week High | $189.58 | $177.40 |
| Indicator | ROST | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 74.43 | 55.00 |
| Support Level | $179.02 | $123.96 |
| Resistance Level | $189.58 | $131.13 |
| Average True Range (ATR) | 2.71 | 2.64 |
| MACD | 0.13 | 0.61 |
| Stochastic Oscillator | 85.09 | 58.44 |
Ross Stores operates as an off-price apparel and accessories retailer with the majority of its sales derived from its Ross Dress for Less banner. The company opportunistically procures excess brand-name merchandise made available via manufacturing overruns and retail liquidation sales at a 20%-60% discount to full prices. As such, its stores are often filled with a vast array of stock-keeping units, each with minimal product depth that creates a treasure hunt shopping experience. The firm's more than 1,900 Ross Dress for Less stores are primarily located in densely populated suburban communities and typically serve middle-income consumers. Ross also operates around 360 DD's Discounts chains targeting lower-income shoppers.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.